Global Markets Direct is a cutting-edge provider of market research and business consultancies for a wide range of customers worldwide.
A team of analytics is capable to produce all sorts of market information and carry out extensive industry research using unique data and reliable sources to let customers know who they are at the market. Global Markets Direct has profound analytical experience in researching the industries and preparing customized reports across many specific fields.
The company is distinguished by its high-quality consulting products and close inspection of the issues under study. Diligent efforts of the experts make every piece of business information an exclusive source of feasible solutions and valuable advice.
With a commitment to serve every client need, Global Markets Direct collects and interprets the materials for the analysis, uses methods of primary and secondary research and develops one of a kind data packages for global clients. They are able to cover the tones of industry-related information to assist customers in taking the right business decisions and developing their strategic plans.
Under the supervision of skillful managers and experts, business analysts produce reports that include:
- Product portfolio
- Potentially strong market reviews
- Competitive analytics
- Prospect partners
- Mergers and acquisitions project data
- Latest trends across a particular industry area
- Research and development strategies
- The analysis of new customers
- A set of remedial measures for projects
They will search for new partners and highlight the current business issues plus develop new strategies and tactical steps to help you take the lead in the industry where you operate.
Publications found:
5,853
Sort by:
Fibrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,500.00
Fibrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Fibrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an ov...
May 2022
214 pages
Flavivirus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,500.00
Flavivirus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Flavivirus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and...
May 2022
277 pages
Follicular Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,500.00
Follicular Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Follicular Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key...
May 2022
323 pages
Follicular Thyroid Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Follicular Thyroid Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Follicular Thyroid Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule T...
May 2022
52 pages
Food Allergy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Food Allergy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Food Allergy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provid...
May 2022
99 pages
Fungal Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,500.00
Fungal Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Fungal Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Play...
May 2022
243 pages
Fungal Keratitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Fungal Keratitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Fungal Keratitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Player...
May 2022
36 pages
Gastric Motility Disorder Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Gastric Motility Disorder Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Gastric Motility Disorder Drugs in Development by Stages, Target, MoA, RoA, Molecule T...
May 2022
36 pages
Gastrointestinal Radiation Toxicity Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Gastrointestinal Radiation Toxicity Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Gastrointestinal Radiation Toxicity Drugs in Development by Stages, Target,...
May 2022
38 pages
Gastroparesis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Gastroparesis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Gastroparesis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players prov...
May 2022
48 pages
Gaucher Disease Type I Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Gaucher Disease Type I Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Gaucher Disease Type I Drugs in Development by Stages, Target, MoA, RoA, Molecule Type an...
May 2022
46 pages
Gaucher Disease Type II Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Gaucher Disease Type II Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Gaucher Disease Type II Drugs in Development by Stages, Target, MoA, RoA, Molecule Type...
May 2022
35 pages
Gaucher Disease Type III Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Gaucher Disease Type III Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Gaucher Disease Type III Drugs in Development by Stages, Target, MoA, RoA, Molecule Typ...
May 2022
41 pages
General Anesthetic Effect Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
General Anesthetic Effect Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY General Anesthetic Effect Drugs in Development by Stages, Target, MoA, RoA, Molecule T...
May 2022
43 pages
Generalized Anxiety Disorder (GAD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Generalized Anxiety Disorder (GAD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Generalized Anxiety Disorder (GAD) Drugs in Development by Stages, Target, Mo...
May 2022
48 pages
Genital Warts (Condylomata Acuminata) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Genital Warts (Condylomata Acuminata) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Genital Warts (Condylomata Acuminata) Drugs in Development by Stages, Targ...
May 2022
57 pages
Geographic Atrophy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Geographic Atrophy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Geographic Atrophy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Pl...
May 2022
77 pages
Germ Cell Tumors Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Germ Cell Tumors Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Germ Cell Tumors Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Player...
May 2022
47 pages
Glycogen Storage Disease 1A Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Glycogen Storage Disease 1A Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Glycogen Storage Disease 1A Drugs in Development by Stages, Target, MoA, RoA, Molecu...
May 2022
38 pages
Glycogen Storage Disorders (GSD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Glycogen Storage Disorders (GSD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Glycogen Storage Disorders (GSD) Drugs in Development by Stages, Target, MoA, R...
May 2022
47 pages
